Archives of Toxicology

, Volume 89, Issue 12, pp 2429–2443 | Cite as

The in vitro PIG-A gene mutation assay: mutagenicity testing via flow cytometry based on the glycosylphosphatidylinositol (GPI) status of TK6 cells

  • Christopher T. Krüger
  • Mareike Hofmann
  • Andrea Hartwig
Genotoxicity and Carcinogenicity

Abstract

The X-linked PIG-A gene is involved in the biosynthesis of the cell surface anchor GPI, and its inactivation may serve as a new marker for mutagenicity. The in vivo PIG-A gene mutation assay is currently being validated by several groups. In this study, we established a corresponding in vitro variant of the PIG-A assay applying B-lymphoblastoid TK6 cells. PE-conjugated antibodies against the GPI-anchored proteins CD55 and CD59 were used to determine the GPI status via multicolor flow cytometry. Mutant spiked TK6 cell samples were analyzed, and mutants were quantified with even small numbers being quantitatively recovered. To validate our approach, mutant spiked cell samples were analyzed by flow cytometry and proaerolysin selection in parallel, yielding a high correlation. Further, we developed a procedure to reduce the background level of preexisting mutant cells to lower than 20 in 106 cells to increase the sensitivity of the assay. Spontaneous rate of GPI deficiency was investigated being 0.76 × 10−6/cell/generation for TK6 cells. The optimal phenotype expression time after ethyl methanesulfonate treatment was found to be 10 days. We applied the in vitro PIG-A assay to demonstrate the mutagenicity of ethyl methanesulfonate, 4-nitroquinoline 1-oxide and UV-C irradiation in a dose-dependent and statistically significant manner. Pyridine and cycloheximide were included as negative controls providing negative test results up to 10 mM. These data suggest that the in vitro PIG-A assay could complement the in vivo PIG-A assay with some distinct advantages compared to other in vitro mammalian mutagenicity tests.

Keywords

GPI PIG-A TK6 Gene mutation assay Flow cytometry 

References

  1. Abrami L et al (1998) The pore-forming toxin proaerolysin is activated by furin. J Biol Chem 273:32656–32661CrossRefPubMedGoogle Scholar
  2. Amundson SA, Liber HL (1991) A comparison of induced mutation at homologous alleles of the tk locus in human cells. Mutat Res Fund Mol Mech Mutagen 247:19–27CrossRefGoogle Scholar
  3. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci 96:5209–5214PubMedCentralCrossRefPubMedGoogle Scholar
  4. Araten D et al (2002) Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia 16:2243CrossRefPubMedGoogle Scholar
  5. Araten DJ, Golde DW, Zhang RH, Thaler HT, Gargiulo L, Notaro R, Luzzatto L (2005) A quantitative measurement of the human somatic mutation rate. Cancer Res 65:8111–8117CrossRefPubMedGoogle Scholar
  6. Araten DJ, Martinez-Climent JA, Perle MA, Holm E, Zamechek L, DiTata K, Sanders KJ (2010) A quantitative analysis of genomic instability in lymphoid and plasma cell neoplasms based on the PIG-A gene. Mutat Res Fund Mol Mech Mutagen 686:1–8CrossRefGoogle Scholar
  7. Beranek DT (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res Fund Mol Mech 231:11–30CrossRefGoogle Scholar
  8. Bessler M et al (1994) Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 13:110PubMedCentralPubMedGoogle Scholar
  9. Bhalli JA, Shaddock JG, Pearce MG, Dobrovolsky VN, Cao X, Heflich RH, Vohr HW (2011) Report on stage III Pig-a mutation assays using benzo [a] pyrene. Environ Mol Mutagen 52:731–737CrossRefPubMedGoogle Scholar
  10. Bryce SM, Bemis JC, Dertinger SD (2008) In vivo mutation assay based on the endogenous Pig-a locus. Environ Mol Mutagen 49:256–264CrossRefPubMedGoogle Scholar
  11. Cammerer Z et al (2011) Report on stage III Pig-a mutation assays using N-ethyl-N-nitrosourea—comparison with other in vivo genotoxicity endpoints. Environ Mol Mutagen 52:721–730CrossRefPubMedGoogle Scholar
  12. Dertinger SD et al (2011) International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories. Environ Mol Mutagen 52:690–698CrossRefPubMedGoogle Scholar
  13. Diep DB, Nelson KL, Raja SM, Pleshak EN, Buckley JT (1998) Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. J Biol Chem 273:2355–2360CrossRefPubMedGoogle Scholar
  14. Dobrovolsky VN, Miura D, Heflich RH, Dertinger SD (2010) The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment. Environ Mol Mutagen 51:825–835CrossRefPubMedGoogle Scholar
  15. Enninga IC, Groenendijk R, Filon A, Van Zeeland A, Simons J (1986) The wavelength dependence of UV-induced pyrimidine dimer formation, cell killing and mutation induction in human diploid skin fibroblasts. Carcinogenesis 7:1829–1836CrossRefPubMedGoogle Scholar
  16. Fellows MD, McDermott A, Clare KR, Doherty A, Aardema MJ (2014) The spectral karyotype of L5178Y TK+/− mouse lymphoma cells clone 3.7. 2C and factors affecting mutant frequency at the thymidine kinase (tk) locus in the microtitre mouse lymphoma assay. Environ Mol Mutagen 55:35–42CrossRefPubMedGoogle Scholar
  17. Fetterhoff T, Holland S, Wile K (1993) Fluorescent detection of non-viable cells in fixed cell preparations. Cytometry 14:27Google Scholar
  18. Furth EE, Thilly WG, Penman BW, Liber HL, Rand WM (1981) Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal Biochem 110:1–8CrossRefPubMedGoogle Scholar
  19. Fuscoe J, Ockey CH, Fox M (1986) Molecular analysis of X-ray-induced mutants at the HPRT locus in V79 Chinese hamster cells. Int J Radiat Biol 49:1011–1020CrossRefGoogle Scholar
  20. Glaab WE, Tindall KR (1997) Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects. Carcinogenesis 18:1–8CrossRefPubMedGoogle Scholar
  21. Green MH, O’Neill JP, Cole J (1995) Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes. Mutat Res Environ Mutagen 334:323–339CrossRefGoogle Scholar
  22. Grosovsky AJ, Parks KK, Giver CR, Nelson SL (1996) Clonal analysis of delayed karyotypic abnormalities and gene mutations in radiation-induced genetic instability. Mol Cell Biol 16:6252–6262PubMedCentralCrossRefPubMedGoogle Scholar
  23. Hillmen P, Bessler M, Mason PJ, Watkins WM, Luzzatto L (1993) Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci 90:5272–5276PubMedCentralCrossRefPubMedGoogle Scholar
  24. Jacobson ED, Krell K, Dempsey MJ (1981) The wavelength dependence of ultraviolet light-induced cell killing and mutagenesis in L5178Y mouse lymphoma cells. J Photochem Photobiol 33:257–260CrossRefGoogle Scholar
  25. Jhappan C, Noonan FP, Merlino G (2003) Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22:3099–3112CrossRefPubMedGoogle Scholar
  26. Kirkland D, Aardema M, Henderson L, Müller L (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res 584:1CrossRefPubMedGoogle Scholar
  27. Kirkland D, Reeve L, Gatehouse D, Vanparys P (2011) A core in vitro genotoxicity battery comprising the ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat Res Genet Toxicol Environ 721:27–73CrossRefGoogle Scholar
  28. Kodama Y, Boreiko CJ, Skopek TR, Recio L (1989) Cytogenetic analysis of spontaneous and 2-cyanoethylene oxide-induced tk−/− mutants in TK6 human lymphoblastoid cultures. Environ Mol Mutagen 14:149–154CrossRefPubMedGoogle Scholar
  29. Koyama N et al (2006) Genotoxicity of acrylamide and glycidamide in human lymphoblastoid TK6 cells. Mutat Res Genet Toxicol Environ 603:151–158CrossRefGoogle Scholar
  30. Krawitz PM et al (2013) A case of paroxysmal nocturnal hemoglobinuria caused by a germline mutation and a somatic mutation in PIGT. Blood 122:1312–1315CrossRefPubMedGoogle Scholar
  31. Luzzatto L (2013) PNH from mutations of another PIG gene. Blood 122:1099–1100CrossRefPubMedGoogle Scholar
  32. Miura D, Dobrovolsky VN, Mittelstaedt RA, Kasahara Y, Katsuura Y, Heflich RH (2008a) development of an in vivo gene mutation assay using the endogenous Pig-A gene: II. Selection of Pig-A Mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ Mol Mutagen 49:622–630CrossRefPubMedGoogle Scholar
  33. Miura D, Dorovolsky VN, Kasahara Y, Katsuura Y, Heflich RH (2008b) Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Environ Mol Mutagen 49:614–621CrossRefPubMedGoogle Scholar
  34. Miura D, Shaddock JG, Mittelstaedt RA, Dobrovolsky VN, Kimoto T, Kasahara Y, Heflich RH (2011) Analysis of mutations in the Pig-a gene of spleen T-cells from N-ethyl-N-nitrosourea-treated fisher 344 rats. Environ Mol Mutagen 52:419–423CrossRefPubMedGoogle Scholar
  35. Morris SM (2002) A role for p53 in the frequency and mechanism of mutation. Mutat Res Rev Mutat 511:45–62CrossRefGoogle Scholar
  36. Nakamura J, Gul H, Tian X, Bultman SJ, Swenberg JA (2012) Detection of PIGO-deficient cells using proaerolysin: a valuable tool to investigate mechanisms of mutagenesis in the DT40 cell system. PLoS ONE 7:e33563PubMedCentralCrossRefPubMedGoogle Scholar
  37. OECD (1997) Organisation for economic co-operation and development (OECD). Test No. 476: in vitro mammalian cell gene mutation testGoogle Scholar
  38. Parker MW, Van Der Goot FG, Buckley JT (2003) Aerolysin—The ins and outs of a model channel-forming toxin. Mol Microbiol 19:205–212CrossRefGoogle Scholar
  39. Parry JM, Parry EM (2012) Methods in molecular biology 817 (springer protocols)—Genetic toxicology: principles and methods. Humana Press, New YorkGoogle Scholar
  40. Peruzzi B, Araten DJ, Notaro R, Luzzatto L (2010) The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. Mutat Res Rev Mutat 705:3–10CrossRefGoogle Scholar
  41. Phonethepswath S, Bryce SM, Bemis JC, Dertinger SD (2008) Erythrocyte-based Pig-a gene mutation assay: demonstration of cross-species potential. Mutat Res Genet Toxicol Environ 657:122–126CrossRefGoogle Scholar
  42. Phonethepswath S et al (2010) Pig-a Mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci 114:59–70PubMedCentralCrossRefPubMedGoogle Scholar
  43. Rosti V, Tremml G, Soares V, Pandolfi PP, Luzzatto L, Bessler M (1997) Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest 100:1028PubMedCentralCrossRefPubMedGoogle Scholar
  44. Rothfuss A et al (2011) Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing. Mutat Res 723:108–120CrossRefPubMedGoogle Scholar
  45. Ryu J-C et al (1999) Mutation spectrum of 4-nitroquinoline N-oxide in the lacI transgenic big blue rat2 cell line. Mutat Res Genet Toxicol Environ 445:127–135CrossRefGoogle Scholar
  46. Schneider-Poetsch T et al (2010) Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat Chem Biol 6:209–217PubMedCentralCrossRefPubMedGoogle Scholar
  47. Schuler M, Gollapudi BB, Thybaud V, Kim JH (2011) Need and potential value of the Pig-a in vivo mutation assay—a hesi perspective. Environ Mol Mutagen 52:685–689CrossRefPubMedGoogle Scholar
  48. Steen AM, Meyer KG, Recio L (1997a) Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1, 2, 3, 4-diepoxybutane. Mutagenesis 12:61–67CrossRefPubMedGoogle Scholar
  49. Steen AM, Meyer KG, Recio L (1997b) Characterization of hprt mutations following l, 2-epoxy-3-butene exposure of human TK6 cells. Mutagenesis 12:359–364CrossRefPubMedGoogle Scholar
  50. Takeda J et al (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703–711CrossRefPubMedGoogle Scholar
  51. Van Zeeland A, Simons J (1976) Linear dose–response relationships after prolonged expression times in V-79 Chinese hamster cells. Mutat Res Fund Mol Mech 35:129–137CrossRefGoogle Scholar
  52. Zölzer F, Kiefer J (1984) Wavelength dependence of inactivation and mutation induction to 6-thioguanine-resistance in V79 Chinese hamster fibroblasts. J Photochem Photobiol 40:49–53CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Christopher T. Krüger
    • 1
  • Mareike Hofmann
    • 1
  • Andrea Hartwig
    • 1
  1. 1.Department of Food Chemistry and Toxicology, Institute for Applied BiosciencesKarlsruhe Institute of Technology (KIT)KarlsruheGermany

Personalised recommendations